Published in Hepatogastroenterology on July 20, 2001
Recent advances in the management of adenocarcinoma of the small intestine. Gastrointest Cancer Res (2009) 1.14
Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg (2006) 1.03
Prognostic factors in primary adenocarcinoma of the small intestine: 13-year single institution experience. World J Surg Oncol (2008) 0.96
Surgically treated primary malignant tumor of small bowel: a clinical analysis. World J Gastroenterol (2010) 0.95
Prognostic factors associated with survival in patients with primary duodenal adenocarcinoma. Korean J Intern Med (2011) 0.89
An elderly woman with triple primary metachronous malignancy: A case report and review of literature. Int J Surg Case Rep (2013) 0.86
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet (2010) 13.59
Orbital and millennial Antarctic climate variability over the past 800,000 years. Science (2007) 5.10
Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg (1998) 4.95
The leader peptide of yeast gene CPA1 is essential for the translational repression of its expression. Cell (1987) 4.91
Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg (1998) 4.86
E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res (1994) 4.51
Dating the rise of atmospheric oxygen. Nature (2004) 4.29
Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol (2001) 4.18
Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg (1993) 3.45
Boerhaave's syndrome: analysis of the literature and report of 18 new cases. Dis Esophagus (1997) 3.06
A clinical pathway to accelerate recovery after colonic resection. Ann Surg (2000) 3.04
Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol (1992) 2.96
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol (2001) 2.91
Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg (2000) 2.85
Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol (2006) 2.84
Heterogeneity in breast cancer and the problem of relevance of findings. Anal Cell Pathol (1999) 2.81
Development of Myocardial Necrosis and Absence of Nerve Degeneration in Thiamine Deficiency in Pigs. Am J Pathol (1943) 2.56
Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg (1992) 2.54
Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut (2003) 2.49
Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg (2001) 2.49
Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J (1990) 2.42
THE EXCRETION OF SPECIFIC FLUORESCENT SUBSTANCES IN THE URINE IN EXPERIMENTAL NICOTINIC ACID DEFICIENCY. J Clin Invest (1942) 2.39
Transoral access for endoscopic thyroid resection. Surg Endosc (2007) 2.38
Inactivation of the protein phosphatase 2A regulatory subunit A results in morphological and transcriptional defects in Saccharomyces cerevisiae. Mol Cell Biol (1992) 2.33
Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol (2000) 2.28
Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer (1996) 2.23
Ethical problems in medical practice. A protocol for the guidance of physicians. West J Med (1982) 2.19
A protein-protein interaction map of yeast RNA polymerase III. Proc Natl Acad Sci U S A (1999) 2.18
Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med (2000) 2.17
Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol (1997) 2.16
Local excision and endoscopic posterior mesorectal resection versus low anterior resection in T1 rectal cancer. Br J Surg (2008) 2.14
The Gorham-Stout syndrome (Gorham's massive osteolysis). A report of six cases with histopathological findings. J Bone Joint Surg Br (1999) 2.07
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04
Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer (1993) 2.01
Tracheobronchial lesions following oesophagectomy: prevalence, predisposing factors and outcome. Br J Surg (1998) 1.99
Suppression of yeast RNA polymerase III mutations by FHL1, a gene coding for a fork head protein involved in rRNA processing. Mol Cell Biol (1994) 1.91
Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol (1989) 1.81
Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol (1998) 1.79
Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg (1998) 1.78
Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg (1995) 1.77
Pretherapeutic laparoscopic staging in advanced gastric carcinoma. Endoscopy (1999) 1.76
Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg (1994) 1.75
Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry (2002) 1.70
Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg (1996) 1.69
Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication. J Gastrointest Surg (1999) 1.69
The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling. Proc Natl Acad Sci U S A (1999) 1.69
Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology (1992) 1.68
Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet (1996) 1.65
From first base: the sequence of the tip of the X chromosome of Drosophila melanogaster, a comparison of two sequencing strategies. Genome Res (2001) 1.64
Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun (1998) 1.64
Pulmonary infections imitating lung cancer: clinical presentation and therapeutical approach. Ir J Med Sci (2012) 1.64
Shared decision making for in-patients with schizophrenia. Acta Psychiatr Scand (2006) 1.63
Effect of histamine H2-receptor blockade on vagally induced gastric secretion in man. Br Med J (1974) 1.63
Social phobia in spasmodic torticollis. J Neurol Neurosurg Psychiatry (2001) 1.62
Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol (1999) 1.61
Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg (2000) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study. Ann Surg (1999) 1.60
Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet (1999) 1.59
Computerized identification of pathologic duodenogastric reflux using 24-hour gastric pH monitoring. Ann Surg (1991) 1.58
Formation of a highly peptide-receptive state of class II MHC. Immunity (1998) 1.58
Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol (2000) 1.57
Serum protein changes during the acute phase reaction. Clin Chim Acta (1969) 1.57
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report. Antimicrob Agents Chemother (1992) 1.57
Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg (1999) 1.56
Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer. Lancet (1994) 1.56
Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg (2001) 1.55
Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity (2000) 1.54
Flexible versus rigid endoscopy for treatment of foreign body impaction in the esophagus. Surg Endosc (2007) 1.54
Boerhaave's syndrome: the man behind the syndrome. Dis Esophagus (1997) 1.53
The role of adherent HLA-DR+ mononuclear cells in autologous and allogeneic MLR. J Immunol (1981) 1.53
[Anastomotic leaks in the upper gastrointestinal tract]. Chirurg (2004) 1.53
Anaerobic pericarditis: case report and review. Clin Infect Dis (1994) 1.52